Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.2%

8 terminated/withdrawn out of 253 trials

Success Rate

92.5%

+5.9% vs industry average

Late-Stage Pipeline

10%

26 trials in Phase 3/4

Results Transparency

5%

5 of 98 completed trials have results

Key Signals

33 recruiting5 with results4 withdrawn

Enrollment Performance

Analytics

N/A
116(65.5%)
Phase 2
20(11.3%)
Phase 3
19(10.7%)
Phase 1
14(7.9%)
Phase 4
7(4.0%)
Early Phase 1
1(0.6%)
177Total
N/A(116)
Phase 2(20)
Phase 3(19)
Phase 1(14)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (253)

Showing 20 of 253 trials
NCT07569679Phase 2Recruiting

Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer

Role: lead

NCT07568626Recruiting

Factors for Prolonged Hospital Stays in Patients Undergoing ERCP

Role: lead

NCT07553780Recruiting

Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer

Role: collaborator

NCT07553754Recruiting

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

Role: collaborator

NCT07157618Recruiting

Prospective Pathology Foundation Models

Role: collaborator

NCT07535138Early Phase 1Not Yet Recruiting

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Role: lead

NCT07531329Recruiting

Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer

Role: collaborator

NCT06084819Phase 2Recruiting

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Role: collaborator

NCT06998784Not ApplicableCompleted

Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Acute Pancreatitis

Role: lead

NCT07073430Recruiting

Application Evaluation Research on the Artificial Intelligence-assisted Support System for the Diagnosis of Colorectal Tubular Adenoma Lesions

Role: collaborator

NCT07365345Not ApplicableRecruiting

Frequency of Electrical Acupoint Stimulation on Hypotension in TAVR Patients

Role: lead

NCT07492927Recruiting

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

Role: collaborator

NCT07474142Recruiting

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

Role: collaborator

NCT06031012Phase 3Completed

Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis

Role: lead

NCT04987086Not ApplicableRecruiting

68Ga-PSMA PET in the Renal Cell Carcinoma

Role: collaborator

NCT07454408Phase 1Not Yet Recruiting

Evaluation of the Outcome of Fecal Microbiota Transplantation

Role: lead

NCT07329660Not ApplicableNot Yet Recruiting

Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients

Role: lead

NCT06068621Phase 2Completed

Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia

Role: collaborator

NCT04320979Phase 3Active Not Recruiting

Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients

Role: collaborator

NCT07338448Not ApplicableNot Yet Recruiting

Electrical Acupoint Stimulation on Gastric Reflux During I-gel Ventilation

Role: lead